Solventum SOLV
NYSE SOLV
$87.79 +0.03 (+0.04%)
As of: Oct 2, 2026 · 9:34 AM EDT

Solventum (SOLV) Liabilities from Discontinued Operations (2025)

Updated

Solventum (SOLV) posted Liabilities from Discontinued Operations of $38 million for Q2 2025, down 19.1% from the prior quarter.

Analysis

Solventum (SOLV) Liabilities from Discontinued Operations (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 Solventum 14.99 Bn 11.51 Bn 1.29 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 38.00 Mn
Mar 31, 2025 47.00 Mn
API Access

Solventum Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=SOLV&period=max&api_key=YOUR_API_KEY